Test Price
2,800 AED✅ Home Collection Available
PARN Gene Pulmonary Fibrosis and Bone Marrow Failure, Telomere-Related Type 4 Genetic Test in UAE | 2800 AED | DHA Certified
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced NGS-based genetic test screens the entire PARN gene for pathogenic variants linked to autosomal dominant telomere-related pulmonary fibrosis and bone marrow failure (type 4). The test provides definitive molecular diagnosis and guides surveillance, family planning, and targeted management in at-risk individuals.
| Feature | Our PARN NGS Test | Closest Alternative (Conventional Sequencing) |
|---|---|---|
| Precision | >99.9% Diagnostic Sensitivity (ISO 9001:2015) | ~95% Sensitivity, no telomere-specific analysis |
| Methodology | Next Generation Sequencing (NGS) – complete coding region + telomere-biology genes | Sanger sequencing of PARN only |
| Turnaround Time | 3–4 Weeks with telephonic post-test clinical guidance | 6–8 Weeks, no clinical correlation support |
| UAE Compliance | DHA/MOHAP Guidelines, ISO-Certified Cold-Chain Home Collection | Not guaranteed |
Physician Insight & Safety Protocols
Medication Advisory
Do not alter or discontinue any prescribed medication without direct consultation with your treating physician. Genetic test results are not a substitute for ongoing medical management.
Safety Exclusion Criteria & Emergency Red Flags
- Active bleeding disorder or unstable anticoagulation therapy.
- Blood transfusion within the past 2 weeks.
- Inability to provide informed consent.
- Individuals under 18 years without parental/legal guardian consent.
- Emergency red flags: Seek immediate care if you develop sudden shortness of breath, fever >38.5°C, or uncontrolled bleeding from the collection site.
Patient FAQ & Clinical Guidance
1. What is the PARN gene test used for?
Snippet: This test identifies genetic variants in PARN causing pulmonary fibrosis and bone marrow failure linked to telomere shortening.
It is a clinical-grade molecular test used to confirm a suspected hereditary telomere biology disorder, guide lung and haematological surveillance, and inform reproductive or pre-symptomatic testing for family members.
2. How is the sample collected and what are the requirements?
Snippet: Sample collection requires a single blood draw, DNA extraction card, or extracted DNA, with genetic counselling beforehand.
Our premium service offers a hospital-grade home phlebotomy visit (8 AM–11 PM) using ISO-certified cold-chain logistics. A pre-test genetic counselling session is mandatory to construct a family pedigree and ensure informed consent. You can provide either whole blood, a drop of blood on an FTA card, or previously extracted DNA.
3. Is the test covered by UAE health insurance?
Snippet: Insurance coverage varies by plan; we provide direct billing verification instantly via WhatsApp at +971 54 548 8731.
Many UAE-based policies now offer genetic testing benefits under DHA/MOHAP preventive genomics guidelines. Contact us to verify your coverage before booking.
4. How long does it take to receive results?
Snippet: Turnaround time is 3–4 weeks from sample receipt, with a telephonic post-test clinical guidance session included.
The NGS analysis, bioinformatics interpretation, and clinical correlation require this duration to ensure accuracy. You will be contacted for a one-on-one discussion of your results with a genetic counsellor.
5. What do the results mean for my family?
Snippet: A pathogenic variant has a 50% chance of being inherited by each child; family cascade testing is recommended.
Genetic counselling for at-risk relatives is strongly advised to enable early surveillance and preventive interventions.
UAE Regulatory & Data Privacy Adherence
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – Data Privacy & Confidentiality
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
- Federal Decree-Law No. 4 of 2016 on Medical Liability – Patient Safety & Informed Consent
- DHA Facility License No. 1143
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139)
Clinical & Logistical Metadata
| Test Name | PARN Gene Pulmonary Fibrosis and Bone Marrow Failure, Telomere-Related Type 4 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | Next Generation Sequencing (NGS) |
| ICD-10-CM Code | J84.10, D61.9 |
| LOINC Code | 21670-8 |
| DHA Facility License & Laboratory Address | Facility License 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians